Articles
6,670 Articles
Psychedelics - Green Market Report
/
Apr 26, 2024
Mydecine will restate 2022 financials, lowering cash levels even further
Mydecine Innovations Group Inc. (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) will restate its previously filed audited financial statements for the fiscal year ended Dec. 31, 2022. Mydecine said the changed financials would result in a lower cash position and increased debts and expenses. Mydecine also...
Psychedelics Today
/
Apr 26, 2024
Psychedelic Education: Insights, Advice, and Where to Start
In this episode, Kyle and Johanna catch up, interviewing each other about psychedelic education and what they’ve learned, the biggest challenges, and what advice they would give to anyone looking to get involved in the psychedelic field. They discuss: and more! The next round of our year-long...
Zen Habits
/
Apr 26, 2024
The Moment That Ruins Our Focus
By Leo Babauta I challenge you to do a test before you read the rest of this post (well OK, read the next two paragraphs then go do the challenge) … Open an email that’s been sitting in your inbox but that you’ve been avoiding responding to or acting on. Pick the hardest one. Try to sit there,...
Psychedelics Today
/
Apr 25, 2024
The Ketamine Conundrum
What if there was a potentially life-saving drug that could relieve depression and PTSD but also, potentially, force frequent users to rush to the toilet every 15 minutes? Well, it does exist. It’s ketamine, the most rapid-acting antidepressant in use today. The drug has morphed in popular...
Ketamine
Psilocybin Alpha
/
Apr 25, 2024
Pα+ Psychedelic Bulletin #162: EQUULUS Therapeutics Emerges from Stealth; Responses to ICER’s Draft Evidence Report on Lykos’ MDMA; and more…
Featured content in this Issue: Companies, organisations and drug candidates mentioned in this Bulletin: EQUULUS Therapeutics; EQL-101; EQL-201; Gilgamesh Pharmaceuticals; DemeRx; atai Life Sciences; Delix Therapeutics; CaaMTech; Lykos Therapeutics; Beckley Psytech; BPL-003; Compass Pathways;...
Psychedelic Invest
/
Apr 24, 2024
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
NEW YORK and BERLIN, April 24, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that the first patient has been dosed in Part 2 of...
Reality Sandwich
/
Apr 24, 2024
How Long Does DMT Stay In Your System?
Dimethyltryptamine, or DMT, is often thought of as the mother of all psychedelics. It is the main chemical component in the drinkable tea ayahuasca, known to produce intense, vivid and sometimes otherworldly effects. When vaporized, DMT acts quickly to alter one’s perception, even producing...
DMT
Ayahuasca
Psychedelics - Green Market Report
/
Apr 24, 2024
Tryp Therapeutics merger with Exopharm approved by shareholders
Clinical-stage psychedelic biotech, Tryp Therapeutics, Inc., has announced that its previously announced plan to merge with Exopharm Limited has received approval from Exopharm’s shareholders. The arrangement, which is expected to close on or about May 1, has satisfied all conditions precedent,...
Psychedelic Invest
/
Apr 24, 2024
MindBio Landmark Sleep Research Published in Prestigious Nature Portfolio Journal Translational Psychiatry
VANCOUVER – MindBio Therapeutics Corp. (CSE: MBIO) (Frankfurt: WF6), (the ‘Company’ or ‘MindBio’), a clinical stage biopharma company uniquely pioneering novel treatments for psychiatric conditions using microdoses of psychedelic medicines is pleased to announce publication of its...
Psychedelic Invest
/
Apr 24, 2024
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its subsidiary Algernon...
DMT
Psychedelics - Green Market Report
/
Apr 23, 2024
Hypha Labs pivots to psilocybin with new mushroom tech
Hypha Labs Inc. (OTC: DIGP), formerly known as Digipath, announced that it is transitioning from the cannabis lab business to focus on psilocybin and other functional mushrooms. “We decided to get out of the cannabis lab business when someone offered us, you know, an amount of money that we...
Reality Sandwich
/
Apr 23, 2024
Psilocybin and Meditation: Unlocking the Potential for Enhancing Insightfulness
A groundbreaking study has provided new insights into the synergistic effects of psilocybin, a psychedelic compound found in magic mushrooms, and meditation on brain function and subjective experience. The research, conducted by a team of neuroscientists and meditation experts, suggests that...
Psilocybin
Psychedelic Invest
/
Apr 23, 2024
Legal Battle Intensifies: The Fight for Psilocybin Use in Terminal Care
The ongoing legal battle between a doctor and the U.S. Drug Enforcement Administration (DEA) over the use of psychedelics, specifically psilocybin, for medical purposes is intensifying. Recently, the DEA asked the Ninth Circuit Court of Appeals to prevent a physician from using psilocybin to treat...
Psilocybin
Psychedelics Today
/
Apr 23, 2024
Decolonization, Difficult Conversations, and the Challenge of Merging Spirituality and Science
In this episode, Joe interviews Philip Wolf: writer, member of Rolling Stone’s Culture Council, founder of Cultivating Spirits (the first company in the U.S. to offer legal culinary cannabis experiences), and founder of CashoM, an education company offering a certificate in cannabis stewardship....
Reality Sandwich
/
Apr 23, 2024
Passover Perspectives: Psychedelics, Moses, and the Burning Bush
As the first star appears in the night sky, marking the onset of Passover, we gather to recount and re-experience a pivotal saga of freedom that is as old as the Jewish people themselves. Passover, or Pesach, commemorates the Exodus when Hebrew slaves were led out of Egypt into the promised land....
DMT
Psilocybin Alpha
/
Apr 23, 2024
Insights from the European Medicines Agency’s Psychedelics Workshop: A Pα+ Dispatch
On Tuesday the 16th and Wednesday the 17th of April, the European Medicines Agency (EMA) hosted a meeting in Amsterdam, “Multi-stakeholder workshop on psychedelics – Towards an EU regulatory framework”. Heavy rain and strong winds earlier in the week stunted Schiphol Airport’s capacity,...
Psychedelics
Psychedelics - Green Market Report
/
Apr 23, 2024
DEA resists permitting psilocybin for terminal patients under ‘Right to Try’
A long-running showdown between a doctor and the U.S. Drug Enforcement Administration that could affect the legal status of psychedelics is heating up. The agency last week urged the Ninth Circuit Court of Appeal to block the physician’s efforts to use psilocybin to treat depression in terminally...
DoubleBlind Mag
/
Apr 23, 2024
Mistaken Autopsy Report Blames Ketamine for Tragic Hot Air Balloon Crash
A pilot involved in a hot air balloon crash in January resulting in four fatalities (the pilot, plus three passengers) is at the center of a multi-pronged reporting blunder by both medical professionals and the media, and it’s shedding light on the harm caused by medical misinformation. The pilot...
Ketamine
Psychedelic Invest
/
Apr 23, 2024
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
TORONTO, April 23, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical...
Psychedelic Invest
/
Apr 23, 2024
Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research
VANCOUVER, British Columbia, April 23, 2024 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, is thrilled to announce an innovative research and development partnership with the Kwantlen...
Psychedelic Invest
/
Apr 23, 2024
Red Light Holland Initiates Psilocybin Extraction Phase with PharmAla Following Successful Testing and Preparation by CCrest Labs
Toronto, Ontario–(Newsfile Corp. – April 23, 2024) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland”), a company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe and a premium brand...
Psilocybin
MDMA
Psychedelic Invest
/
Apr 23, 2024
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
SARASOTA, FL, April 23, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today...
Reality Sandwich
/
Apr 22, 2024
An Earnest Defense of Recreational Use (#LSD)
Do you smoke?“No.”Have you ever smoked, or used other tobacco products?“No.” There has been the occasional cigar, and half a century ago, among college friends, plenty of joints, not to mention pipefuls of weed or hashish or kief. But I’m pretty sure these Indiana nurses have Marlboros...
LSD
Psychedelic Invest
/
Apr 22, 2024
FSD Pharma Provides Another Update on Celly Nu’s Anticipated Launch of unbuzzd(TM)
TORONTO, ON / ACCESSWIRE / April 22, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma“), provides an update by way of a news release issued by Celly Nutrition Corp. (“Celly Nu“), and its launching of unbuzzd™, an innovative beverage product that is scientifically...
DoubleBlind Mag
/
Apr 22, 2024
Songwriter Indigo De Souza Credits Macrodosing for Inspiring Her Craft
This interview is a part of DoubleBlind’s Medicine Music series, in partnership with PORTAL, a campaign to destigmatize the responsible use of psychedelics. For video interviews with musicians about their relationship to plant medicines, check out DoubleBlind’s YouTube. Microdosing may be a...
Psychedelics Today
/
Apr 20, 2024
Self Awareness and Inner Work: Essential Skills for Psychedelic-Informed Practitioners
Join us for a free webinar on the importance of self-awareness for psychedelic practitioners. In this workshop, you will learn: This workshop is designed for psychedelic practitioners of all levels of experience. RSVP today to reserve your spot now!
DoubleBlind Mag
/
Apr 19, 2024
Visiting the Dark Side of the Moon
In 585 BC, the astronomer Thales of Miletus predicted that a total solar eclipse would pass directly over the frontlines of a bitterly fought six-year war. The Greek historian Herodotus credited Thales’s accurate premonition—the first ever recorded—with swiftly ending the conflict. Flash...
Psychedelics Today
/
Apr 19, 2024
The Microdosing Effect: Connecting the Dots Between Anecdote and Evidence
In 2024, the discourse around the effects of microdosing psychedelics is deeply polarized. Positioned at opposite ends of the conversation are microdosing evangelists who swear by its benefits and skeptical scientists demanding more empirical evidence. Ask whether it ‘works,’ and you’ll...
Reality Sandwich
/
Apr 19, 2024
The Hundredth Monkey Effect and Collective Consciousness
Perhaps you’ve heard of the Stoned Ape Theory, which suggests that psychedelics played a part in human evolution. While monkeys are involved in both of these theories, the Hundredth Monkey Effect is centered around the concept of collective consciousness. In the 1970s, a captivating story about...
Zen Habits
/
Apr 19, 2024
The Focus of a Monk
By Leo Babauta As I write this, I’m on a long plane ride — I’ve written many posts on planes and trains, and I find it actually much easier to write this way despite the shakiness of my laptop on these rides. It’s easy to write on planes and trains because there’s not as much to do. I...
Psychedelic Invest
/
Apr 19, 2024
PharmAla Closes Private Placement and Concurrent Debt Settlement
VANCOUVER, British Columbia, April 19, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class...
MDMA
Psychedelic Invest
/
Apr 19, 2024
Psychedelics Can Offer More Than Therapy On Its Own
The burgeoning interest in incorporating psychedelics into therapeutic practices has seen a marked rise over the past few years. Recent studies have revealed the potential benefits of substances like psilocybin, LSD, and ketamine in managing various mental health disorders. Therapists point out that...
MDMA
Psychedelics
Reality Sandwich
/
Apr 19, 2024
Sea Moss Benefits, Nutrition, and Ways to Consume
Eating seaweed is not a foreign concept, as many of us enjoy sushi rolls, nori wraps, and soups filled with this green goodness from the ocean. But there’s another sea specimen making a name for itself right now, and it comes in a variety of formats—sea moss. Sea moss might not seem like...
Psychedelics Today
/
Apr 19, 2024
Bicycle day Reflections, Quantum Mechanics, and the Value in Studying Philosophy to Understand Psychedelic Experiences
In this episode, Joe and Kyle interview Lenny Gibson, Ph.D.: philosopher, Grof-certified Holotropic Breathwork® facilitator, 20-year professor of transpersonal psychology at Burlington College, and the reason Joe and Kyle met many years ago. He talks about his early LSD experiences and how his...
LSD
Psychedelic Invest
/
Apr 19, 2024
What is Bicycle Day?
Most people are familiar with the term “420,” a day celebrated in cannabis culture, but there’s another significant drug-related celebration this month that often doesn’t get as much attention: Bicycle Day. Bicycle Day, observed on April 19, pays homage to the discovery of LSD’s effects by...
LSD